Home > Insider Trading > Filing (0001181431-13-041162)

Filing Details

Accession Number:: 0001181431-13-041162
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-07-23 19:11:00
Reporting Period:: 2013-07-23

Filing Date:: 2013-07-23
Accepted Time:: 2013-07-23 19:11:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1302573	Oncomed Pharmaceuticals Inc	OMED	Pharmaceutical Preparations (2834)	383572512

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1048637	M Philip Young	2735 Sand Hill Road Menlo Park CA 94025	No	No	Yes	No
1225484	C L L Viii Group Management Presidio	2735 Sand Hill Road Menlo Park CA 94025	No	No	Yes	No
1474322	M Casey Tansey	2735 Sand Hill Road Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-23	1,028,381	$0.00	1,028,381	No	4	C	Indirect	Directly owned by USVP VIII
Common Stock	Acquisiton	2013-07-23	1,215,407	$0.00	2,243,788	No	4	C	Indirect	Directly owned by USVP VIII
Common Stock	Acquisiton	2013-07-23	1,505,032	$0.00	3,748,820	No	4	C	Indirect	Directly owned by USVP VIII
Common Stock	Acquisiton	2013-07-23	155,164	$17.00	3,903,984	No	4	P	Indirect	Directly owned by USVP VIII
Common Stock	Acquisiton	2013-07-23	9,505	$0.00	9,505	No	4	C	Indirect	Directly owned by EP VIII-A
Common Stock	Acquisiton	2013-07-23	11,233	$0.00	20,738	No	4	C	Indirect	Directly owned by EP VIII-A
Common Stock	Acquisiton	2013-07-23	13,910	$0.00	34,648	No	4	C	Indirect	Directly owned by EP VIII-A
Common Stock	Acquisiton	2013-07-23	1,434	$17.00	36,082	No	4	P	Indirect	Directly owned by EP VIII-A
Common Stock	Acquisiton	2013-07-23	4,817	$0.00	4,817	No	4	C	Indirect	Directly owned by EP VIII-B
Common Stock	Acquisiton	2013-07-23	5,694	$0.00	10,511	No	4	C	Indirect	Directly owned by EP VIII-B
Common Stock	Acquisiton	2013-07-23	7,051	$0.00	17,562	No	4	C	Indirect	Directly owned by EP VIII-B
Common Stock	Acquisiton	2013-07-23	727	$17.00	18,289	No	4	P	Indirect	Directly owned by EP VIII-B
Common Stock	Acquisiton	2013-07-23	9,926	$0.00	9,926	No	4	C	Indirect	Directly owned by AFF VIII
Common Stock	Acquisiton	2013-07-23	11,731	$0.00	21,657	No	4	C	Indirect	Directly owned by AFF VIII
Common Stock	Acquisiton	2013-07-23	14,527	$0.00	36,184	No	4	C	Indirect	Directly owned by AFF VIII
Common Stock	Acquisiton	2013-07-23	1,498	$17.00	37,682	No	4	P	Indirect	Directly owned by AFF VIII

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Directly owned by USVP VIII
No	4	C	Indirect	Directly owned by USVP VIII
No	4	C	Indirect	Directly owned by USVP VIII
No	4	P	Indirect	Directly owned by USVP VIII
No	4	C	Indirect	Directly owned by EP VIII-A
No	4	C	Indirect	Directly owned by EP VIII-A
No	4	C	Indirect	Directly owned by EP VIII-A
No	4	P	Indirect	Directly owned by EP VIII-A
No	4	C	Indirect	Directly owned by EP VIII-B
No	4	C	Indirect	Directly owned by EP VIII-B
No	4	C	Indirect	Directly owned by EP VIII-B
No	4	P	Indirect	Directly owned by EP VIII-B
No	4	C	Indirect	Directly owned by AFF VIII
No	4	C	Indirect	Directly owned by AFF VIII
No	4	C	Indirect	Directly owned by AFF VIII
No	4	P	Indirect	Directly owned by AFF VIII

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2013-07-23	1,028,381	$0.00	1,028,381	$0.00
Common Stock	Series A Preferred Stock	Disposition	2013-07-23	9,505	$0.00	9,505	$0.00
Common Stock	Series A Preferred Stock	Disposition	2013-07-23	4,817	$0.00	4,817	$0.00
Common Stock	Series A Preferred Stock	Disposition	2013-07-23	9,926	$0.00	9,926	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	1,215,407	$0.00	1,215,407	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	11,233	$0.00	11,233	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	5,694	$0.00	5,694	$0.00
Common Stock	Series B Preferred Stock	Disposition	2013-07-23	11,731	$0.00	11,731	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	1,505,032	$0.00	1,505,032	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	13,910	$0.00	13,910	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	7,051	$0.00	7,051	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2013-07-23	14,527	$0.00	14,527	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Each share of Series A, Series B and Series B-1 Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering on July 23, 2013.
The reported securities are owned directly by each of U.S. Venture Partners VIII, L.P. ("USVP VIII"), USVP VIII Affiliates Fund, L.P. ("AFF VIII"), USVP Entrepreneur Partners VIII-A, L.P. ("EP VIII-A") and USVP Entrepreneur Partners VIII-B, L.P. ("EP VIII-B" and together with USVP VIII, AFF VIII and EP VIII-A, the "USVP Funds"). Presidio Management Group VIII, LLC, or PMG VIII, is the general partner of the USVP Funds, and may be deemed to have sole voting and dispositive power over the shares held by the USVP Funds. PMG VIII and Irwin Federman, Winston Fu, Steven Krausz, David Liddle, Jonathan Root, Christopher Rust, Casey Tansey and Philip Young, the managing members of PMG VII, who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the USVP Funds except to the extent of any pecuniary interest therein.
The securities are immediately convertible.
The expiration date is not relevant to the conversion of these securities.